8 research outputs found
Profiling 976 ToxCast Chemicals across 331 Enzymatic and Receptor Signaling Assays
Understanding potential health risks
is a significant challenge
due to the large numbers of diverse chemicals with poorly characterized
exposures and mechanisms of toxicities. The present study analyzes
976 chemicals (including failed pharmaceuticals, alternative plasticizers,
food additives, and pesticides) in Phases I and II of the U.S. EPA’s
ToxCast project across 331 cell-free enzymatic and ligand-binding
high-throughput screening (HTS) assays. Half-maximal activity concentrations
(AC50) were identified for 729 chemicals in 256 assays (7,135 chemical–assay
pairs). Some of the most commonly affected assays were CYPs (CYP2C9
and CYP2C19), transporters (mitochondrial TSPO, norepinephrine, and
dopaminergic), and GPCRs (aminergic). Heavy metals, surfactants, and
dithiocarbamate fungicides showed promiscuous but distinctly different
patterns of activity, whereas many of the pharmaceutical compounds
showed promiscuous activity across GPCRs. Literature analysis confirmed
>50% of the activities for the most potent chemical–assay
pairs
(54) but also revealed 10 missed interactions. Twenty-two chemicals
with known estrogenic activity were correctly identified for the majority
(77%), missing only the weaker interactions. In many cases, novel
findings for previously unreported chemical–target combinations
clustered with known chemical–target interactions. Results
from this large inventory of chemical–biological interactions
can inform read-across methods as well as link potential targets to
molecular initiating events in adverse outcome pathways for diverse
toxicities
Profiling 976 ToxCast Chemicals across 331 Enzymatic and Receptor Signaling Assays
Understanding potential health risks
is a significant challenge
due to the large numbers of diverse chemicals with poorly characterized
exposures and mechanisms of toxicities. The present study analyzes
976 chemicals (including failed pharmaceuticals, alternative plasticizers,
food additives, and pesticides) in Phases I and II of the U.S. EPA’s
ToxCast project across 331 cell-free enzymatic and ligand-binding
high-throughput screening (HTS) assays. Half-maximal activity concentrations
(AC50) were identified for 729 chemicals in 256 assays (7,135 chemical–assay
pairs). Some of the most commonly affected assays were CYPs (CYP2C9
and CYP2C19), transporters (mitochondrial TSPO, norepinephrine, and
dopaminergic), and GPCRs (aminergic). Heavy metals, surfactants, and
dithiocarbamate fungicides showed promiscuous but distinctly different
patterns of activity, whereas many of the pharmaceutical compounds
showed promiscuous activity across GPCRs. Literature analysis confirmed
>50% of the activities for the most potent chemical–assay
pairs
(54) but also revealed 10 missed interactions. Twenty-two chemicals
with known estrogenic activity were correctly identified for the majority
(77%), missing only the weaker interactions. In many cases, novel
findings for previously unreported chemical–target combinations
clustered with known chemical–target interactions. Results
from this large inventory of chemical–biological interactions
can inform read-across methods as well as link potential targets to
molecular initiating events in adverse outcome pathways for diverse
toxicities
Real-Time Growth Kinetics Measuring Hormone Mimicry for ToxCast Chemicals in T‑47D Human Ductal Carcinoma Cells
High-throughput
screening (HTS) assays capable of profiling thousands of environmentally
relevant chemicals for <i>in vitro</i> biological activity
provide useful information on the potential for disrupting endocrine
pathways. Disruption of the estrogen signaling pathway has been implicated
in a variety of adverse health effects including impaired development,
reproduction, and carcinogenesis. The estrogen-responsive human mammary
ductal carcinoma cell line T-47D was exposed to 1815 ToxCast chemicals
comprising pesticides, industrial chemicals, pharmaceuticals, personal
care products, cosmetics, food ingredients, and other chemicals with
known or suspected human exposure potential. Cell growth kinetics
were evaluated using real-time cell electronic sensing. T-47D cells
were exposed to eight concentrations (0.006–100 μM),
and measurements of cellular impedance were repeatedly recorded for
105 h. Chemical effects were evaluated based on potency (concentration
at which response occurs) and efficacy (extent of response). A linear
growth response was observed in response to prototypical estrogen
receptor agonists (17β-estradiol, genistein, bisphenol A, nonylphenol,
and 4-<i>tert</i>-octylphenol). Several compounds, including
bisphenol A and genistein, induced cell growth comparable in efficacy
to that of 17β-estradiol, but with decreased potency. Progestins,
androgens, and corticosteroids invoked a biphasic growth response
indicative of changes in cell number or cell morphology. Results from
this cell growth assay were compared with results from additional
estrogen receptor (ER) binding and transactivation assays. Chemicals
detected as active in both the cell growth and ER receptor binding
assays demonstrated potencies highly correlated with two ER transactivation
assays (<i>r</i> = 0.72; <i>r</i> = 0.70). While
ER binding assays detected chemicals that were highly potent or efficacious
in the T-47D cell growth and transactivation assays, the binding assays
lacked sensitivity in detecting weakly active compounds. In conclusion,
this cell-based assay rapidly detects chemical effects on T-47D growth
and shows potential, in combination with other HTS assays, to detect
environmentally relevant chemicals with potential estrogenic activity
Real-Time Growth Kinetics Measuring Hormone Mimicry for ToxCast Chemicals in T‑47D Human Ductal Carcinoma Cells
High-throughput
screening (HTS) assays capable of profiling thousands of environmentally
relevant chemicals for <i>in vitro</i> biological activity
provide useful information on the potential for disrupting endocrine
pathways. Disruption of the estrogen signaling pathway has been implicated
in a variety of adverse health effects including impaired development,
reproduction, and carcinogenesis. The estrogen-responsive human mammary
ductal carcinoma cell line T-47D was exposed to 1815 ToxCast chemicals
comprising pesticides, industrial chemicals, pharmaceuticals, personal
care products, cosmetics, food ingredients, and other chemicals with
known or suspected human exposure potential. Cell growth kinetics
were evaluated using real-time cell electronic sensing. T-47D cells
were exposed to eight concentrations (0.006–100 μM),
and measurements of cellular impedance were repeatedly recorded for
105 h. Chemical effects were evaluated based on potency (concentration
at which response occurs) and efficacy (extent of response). A linear
growth response was observed in response to prototypical estrogen
receptor agonists (17β-estradiol, genistein, bisphenol A, nonylphenol,
and 4-<i>tert</i>-octylphenol). Several compounds, including
bisphenol A and genistein, induced cell growth comparable in efficacy
to that of 17β-estradiol, but with decreased potency. Progestins,
androgens, and corticosteroids invoked a biphasic growth response
indicative of changes in cell number or cell morphology. Results from
this cell growth assay were compared with results from additional
estrogen receptor (ER) binding and transactivation assays. Chemicals
detected as active in both the cell growth and ER receptor binding
assays demonstrated potencies highly correlated with two ER transactivation
assays (<i>r</i> = 0.72; <i>r</i> = 0.70). While
ER binding assays detected chemicals that were highly potent or efficacious
in the T-47D cell growth and transactivation assays, the binding assays
lacked sensitivity in detecting weakly active compounds. In conclusion,
this cell-based assay rapidly detects chemical effects on T-47D growth
and shows potential, in combination with other HTS assays, to detect
environmentally relevant chemicals with potential estrogenic activity
Real-Time Growth Kinetics Measuring Hormone Mimicry for ToxCast Chemicals in T‑47D Human Ductal Carcinoma Cells
High-throughput
screening (HTS) assays capable of profiling thousands of environmentally
relevant chemicals for <i>in vitro</i> biological activity
provide useful information on the potential for disrupting endocrine
pathways. Disruption of the estrogen signaling pathway has been implicated
in a variety of adverse health effects including impaired development,
reproduction, and carcinogenesis. The estrogen-responsive human mammary
ductal carcinoma cell line T-47D was exposed to 1815 ToxCast chemicals
comprising pesticides, industrial chemicals, pharmaceuticals, personal
care products, cosmetics, food ingredients, and other chemicals with
known or suspected human exposure potential. Cell growth kinetics
were evaluated using real-time cell electronic sensing. T-47D cells
were exposed to eight concentrations (0.006–100 μM),
and measurements of cellular impedance were repeatedly recorded for
105 h. Chemical effects were evaluated based on potency (concentration
at which response occurs) and efficacy (extent of response). A linear
growth response was observed in response to prototypical estrogen
receptor agonists (17β-estradiol, genistein, bisphenol A, nonylphenol,
and 4-<i>tert</i>-octylphenol). Several compounds, including
bisphenol A and genistein, induced cell growth comparable in efficacy
to that of 17β-estradiol, but with decreased potency. Progestins,
androgens, and corticosteroids invoked a biphasic growth response
indicative of changes in cell number or cell morphology. Results from
this cell growth assay were compared with results from additional
estrogen receptor (ER) binding and transactivation assays. Chemicals
detected as active in both the cell growth and ER receptor binding
assays demonstrated potencies highly correlated with two ER transactivation
assays (<i>r</i> = 0.72; <i>r</i> = 0.70). While
ER binding assays detected chemicals that were highly potent or efficacious
in the T-47D cell growth and transactivation assays, the binding assays
lacked sensitivity in detecting weakly active compounds. In conclusion,
this cell-based assay rapidly detects chemical effects on T-47D growth
and shows potential, in combination with other HTS assays, to detect
environmentally relevant chemicals with potential estrogenic activity
Real-Time Growth Kinetics Measuring Hormone Mimicry for ToxCast Chemicals in T‑47D Human Ductal Carcinoma Cells
High-throughput
screening (HTS) assays capable of profiling thousands of environmentally
relevant chemicals for <i>in vitro</i> biological activity
provide useful information on the potential for disrupting endocrine
pathways. Disruption of the estrogen signaling pathway has been implicated
in a variety of adverse health effects including impaired development,
reproduction, and carcinogenesis. The estrogen-responsive human mammary
ductal carcinoma cell line T-47D was exposed to 1815 ToxCast chemicals
comprising pesticides, industrial chemicals, pharmaceuticals, personal
care products, cosmetics, food ingredients, and other chemicals with
known or suspected human exposure potential. Cell growth kinetics
were evaluated using real-time cell electronic sensing. T-47D cells
were exposed to eight concentrations (0.006–100 μM),
and measurements of cellular impedance were repeatedly recorded for
105 h. Chemical effects were evaluated based on potency (concentration
at which response occurs) and efficacy (extent of response). A linear
growth response was observed in response to prototypical estrogen
receptor agonists (17β-estradiol, genistein, bisphenol A, nonylphenol,
and 4-<i>tert</i>-octylphenol). Several compounds, including
bisphenol A and genistein, induced cell growth comparable in efficacy
to that of 17β-estradiol, but with decreased potency. Progestins,
androgens, and corticosteroids invoked a biphasic growth response
indicative of changes in cell number or cell morphology. Results from
this cell growth assay were compared with results from additional
estrogen receptor (ER) binding and transactivation assays. Chemicals
detected as active in both the cell growth and ER receptor binding
assays demonstrated potencies highly correlated with two ER transactivation
assays (<i>r</i> = 0.72; <i>r</i> = 0.70). While
ER binding assays detected chemicals that were highly potent or efficacious
in the T-47D cell growth and transactivation assays, the binding assays
lacked sensitivity in detecting weakly active compounds. In conclusion,
this cell-based assay rapidly detects chemical effects on T-47D growth
and shows potential, in combination with other HTS assays, to detect
environmentally relevant chemicals with potential estrogenic activity
Using High-Content Screening Data from ToxCast to Analyze Cell State Trajectories
Presented at the Annual Society of Toxicology meetin
Using High-Content Screening Data from ToxCast to Analyze Cell State Trajectories
Presented at the Annual Society of Toxicology meetin